300 related articles for article (PubMed ID: 19352394)
21. Development and internal validation of prediction models for biochemical failure and composite failure after focal salvage high intensity focused ultrasound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses.
Peters M; Kanthabalan A; Shah TT; McCartan N; Moore CM; Arya M; van der Voort van Zyp JR; Moerland MA; Hindley RG; Emberton M; Ahmed HU
Urol Oncol; 2018 Jan; 36(1):13.e1-13.e10. PubMed ID: 28927782
[TBL] [Abstract][Full Text] [Related]
22. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
[TBL] [Abstract][Full Text] [Related]
23. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
24. Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer.
Blana A; Rogenhofer S; Ganzer R; Lunz JC; Schostak M; Wieland WF; Walter B
Urology; 2008 Dec; 72(6):1329-33; discussion 1333-4. PubMed ID: 18829078
[TBL] [Abstract][Full Text] [Related]
25. Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer.
Annoot A; Olivier J; Valtille P; Deken V; Leroy X; Puech P; Villers A
World J Urol; 2019 Feb; 37(2):261-268. PubMed ID: 30116963
[TBL] [Abstract][Full Text] [Related]
26. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
[TBL] [Abstract][Full Text] [Related]
27. The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial.
Joshi A; Roberts MJ; Perera M; Williams E; Rhee H; Pryor D; Lehman M; Heathcote P; Wood S; Coucher J; Gustafson S; Miles K; Vela I
Clin Exp Metastasis; 2020 Aug; 37(4):551-560. PubMed ID: 32519046
[TBL] [Abstract][Full Text] [Related]
28. MR-Guided High-Intensity Directional Ultrasound Ablation of Prostate Cancer.
Galgano SJ; Planz VB; Arora S; Rais-Bahrami S
Curr Urol Rep; 2021 Jan; 22(1):3. PubMed ID: 33403460
[TBL] [Abstract][Full Text] [Related]
29. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
[TBL] [Abstract][Full Text] [Related]
30. Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer.
Koch MO; Gardner T; Cheng L; Fedewa RJ; Seip R; Sanghvi NT
J Urol; 2007 Dec; 178(6):2366-70; discussion 2370-1. PubMed ID: 17936800
[TBL] [Abstract][Full Text] [Related]
31. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
32. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
[TBL] [Abstract][Full Text] [Related]
33. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer.
Dickinson L; Ahmed HU; Hindley RG; McCartan N; Freeman A; Allen C; Emberton M; Kirkham AP
Urol Oncol; 2017 Jan; 35(1):30.e9-30.e15. PubMed ID: 27663393
[TBL] [Abstract][Full Text] [Related]
34. Evolution and outcomes of 3 MHz high intensity focused ultrasound therapy for localized prostate cancer during 15 years.
Thüroff S; Chaussy C
J Urol; 2013 Aug; 190(2):702-10. PubMed ID: 23415962
[TBL] [Abstract][Full Text] [Related]
35. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
[TBL] [Abstract][Full Text] [Related]
36. Role of transrectal ultrasonography in prostate cancer.
Ghai S; Toi A
Radiol Clin North Am; 2012 Nov; 50(6):1061-73. PubMed ID: 23122038
[TBL] [Abstract][Full Text] [Related]
37. A biomedical engineering approach to mitigate the errors of prostate biopsy.
Ahmed HU; Emberton M; Kepner G; Kepner J
Nat Rev Urol; 2012 Feb; 9(4):227-31. PubMed ID: 22310216
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression.
Johnson LM; Rothwax JT; Turkbey B; Rais-Bahrami S; Wood BJ; Figg WD; Choyke PL; Merino MJ; Pinto PA
J Comput Assist Tomogr; 2014; 38(4):565-7. PubMed ID: 24733004
[TBL] [Abstract][Full Text] [Related]
39. [Localized prostate cancer treatment in renal transplant patient with high intensity focalized ultrasound (HIFU)].
Lledó García E; Jara Rascón J; Díez Cordero JM; Subirá Ríos D; Alvarado A; Fernández de Lomana FA; Hernández Fernández C
Actas Urol Esp; 2005 Jan; 29(1):70-3. PubMed ID: 15786766
[TBL] [Abstract][Full Text] [Related]
40. Contrast-Enhanced Transrectal Ultrasound in Focal Therapy for Prostate Cancer.
Ashrafi AN; Nassiri N; Gill IS; Gulati M; Park D; de Castro Abreu AL
Curr Urol Rep; 2018 Aug; 19(10):87. PubMed ID: 30155585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
